References and Notes
<A NAME="RU08507ST-1A">1a</A>
Fleming I.
Frontier Orbitals and Organic Chemical Reactions
Wiley-Interscience;
New York:
1996.
<A NAME="RU08507ST-1B">1b</A>
Herrmann JL.
Kieczykowski GR.
Schlessinger RH.
Tetrahedron Lett.
1973,
26:
2433
<A NAME="RU08507ST-2A">2a</A>
Lansbury PT.
Erwin RW.
Tetrahedron Lett.
1978,
19:
2675
<A NAME="RU08507ST-2B">2b</A>
Lansbury PT.
Erwin RW.
Jeffrey DA.
J. Am. Chem. Soc.
1980,
102:
1602
<A NAME="RU08507ST-2C">2c</A>
Lansbury PT.
Bebernitz GE.
Maynard SC.
Spagnuolo CJ.
Tetrahedron Lett.
1985,
26:
169
<A NAME="RU08507ST-2D">2d</A>
Lansbury PT.
Spagnuolo CJ.
Grimm EL.
Tetrahedron Lett.
1986,
27:
2725
<A NAME="RU08507ST-3A">3a</A>
Katzenellenbogen JA.
Crumrine AL.
J. Am. Chem. Soc.
1974,
96:
5662
<A NAME="RU08507ST-3B">3b</A>
Katzenellenbogen JA.
Crumrine AL.
J. Am. Chem. Soc.
1976,
98:
4925
<A NAME="RU08507ST-3C">3c</A>
Pitzele BS.
Baran JS.
Steinman DH.
Tetrahedron
1976,
32:
1347
<A NAME="RU08507ST-3D">3d</A>
Savu PM.
Katzenellenbogen JA.
J. Org. Chem.
1981,
46:
239
<A NAME="RU08507ST-4A">4a</A>
Fleming I.
Goldhill J.
Paterson I.
Tetrahedron Lett.
1979,
20:
3209
<A NAME="RU08507ST-4B">4b</A>
Fleming I.
Lee TV.
Tetrahedron Lett.
1981,
22:
705
For other approaches, see:
<A NAME="RU08507ST-5A">5a</A>
Bryson TA.
Gammill RB.
Tetrahedron Lett.
1974,
15:
3963
<A NAME="RU08507ST-5B">5b</A>
Pitzele BS.
Baran JSD.
Steinman H.
Tetrahedron
1976,
32:
1347
<A NAME="RU08507ST-5C">5c</A>
Wenkert E.
Goodwin TE.
Ranu BC.
J. Org. Chem.
1977,
42:
2137
<A NAME="RU08507ST-5D">5d</A>
Majewski M.
Mpango GB.
Thomas MT.
Wu A.
Snieckus V.
J. Org. Chem.
1981,
46:
2029
<A NAME="RU08507ST-5E">5e</A>
Paquette LA.
Kinney WA.
Tetrahedron Lett.
1982,
23:
131
<A NAME="RU08507ST-6A">6a</A>
Kim S.
Lim CJ.
Song C.
Chung W.-j.
J. Am. Chem. Soc.
2002,
124:
14306
<A NAME="RU08507ST-6B">6b</A>
Kim S.
Lim CJ.
Angew. Chem. Int. Ed.
2004,
43:
5378
For other radical-mediated alkylations, see:
<A NAME="RU08507ST-7A">7a</A>
Watanabe Y.
Yoneda T.
Ueno Y.
Toru T.
Tetrahedron Lett.
1990,
31:
6669
<A NAME="RU08507ST-7B">7b</A>
Renaud P.
Vionnet J.-P.
Vogel P.
Tetrahedron Lett.
1991,
32:
3491
<A NAME="RU08507ST-7C">7c</A>
Miura K.
Fujisawa N.
Saito H.
Wang D.
Hosomi A.
Org. Lett.
2001,
3:
2591
<A NAME="RU08507ST-7D">7d</A>
Roepel MG.
Tetrahedron Lett.
2002,
43:
1973
<A NAME="RU08507ST-7E">7e</A>
Cai Y.
Roberts BP.
Tetrahedron Lett.
2003,
44:
4645
<A NAME="RU08507ST-8A">8a</A>
Dannley RL.
Jalics G.
J. Org. Chem.
1965,
30:
3848
<A NAME="RU08507ST-8B">8b</A>
Shubber AK.
Dannley RL.
J. Org. Chem.
1971,
36:
3784
For tin-free radical reactions, see:
<A NAME="RU08507ST-9A">9a</A>
Baguley PA.
Walton JC.
Angew. Chem. Int. Ed.
1998,
37:
3072 ; and references therein
<A NAME="RU08507ST-9B">9b</A>
Kim S.
Song H.-J.
Choi T.-L.
Yoon J.-Y.
Angew. Chem. Int. Ed.
2001,
40:
2524
<A NAME="RU08507ST-9C">9c</A>
Kim S.
Lim CJ.
Angew. Chem. Int. Ed.
2002,
41:
3265
<A NAME="RU08507ST-9D">9d</A>
Kim S.
Lim CJ.
Bull. Korean Chem. Soc.
2003,
20:
1219
<A NAME="RU08507ST-10">10</A>
Cai Y.
Roberts BP.
Tocher DA.
Barnett SA.
Org. Biomol. Chem.
2004,
2:
2517
<A NAME="RU08507ST-11A">11a</A>
Curran DP.
Kim D.
Tetrahedron
1991,
47:
6171
<A NAME="RU08507ST-11B">11b</A>
Curran DP.
Kim D.
Ziegler C.
Tetrahedron
1991,
47:
6189
<A NAME="RU08507ST-11C">11c</A>
Curran DP.
Thoma G.
J. Am. Chem. Soc.
1992,
114:
4436
<A NAME="RU08507ST-11D">11d</A>
Curran DP.
Thoma G.
Tetrahedron Lett.
1991,
32:
6307
<A NAME="RU08507ST-12">12</A>
Sakaitani M.
Ohfune Y.
J. Org. Chem.
1990,
55:
870
<A NAME="RU08507ST-13">13</A>
Typical Experimental Procedure
A benzene solution (1 mL, 0.2 M in iodide) of iodomethyl phenyl sulfone (56 mg, 0.2
mmol), O-tert-alkyl dienol ether (9a, 93 mg, 0.3 mmol), and DLP (8 mg, 0.02 mmol) was degassed with nitrogen for 10 min
and then the solution was stirred at 90 °C under nitrogen for 5 h. The solvent was
evaporated under reduced pressure and the residue was diluted with THF (1 mL). Then,
TBAF (240 µL, 0.24 mmol) and MeI (50 µL, 0.8 mmol) were added successively. The reaction
mixture was allowed to stir at r.t. for 2 h. The reaction mixture was diluted with
Et2O, quenched with aq NH4Cl and washed with H2O and brine. The organic layer was dried over anhyd MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified
by silica gel column chromatography using EtOAc-n-hexane (1:10) as eluant to give 5-benzenesulfonylpent-2-enoic acid methyl ester (20a, 45 mg, 89%). 1H NMR (400 MHz, CDCl3): δ = 2.57-2.63 (m, 2 H), 3.16-3.20 (m, 2 H), 3.67 (s, 3 H), 5.79 (dt, J = 15.6, 1.3 Hz, 1 H), 6.78 (dt, J = 15.6, 6.8 Hz, 1 H), 7.53-7.57 (m, 2 H), 7.62-7.66 (m, 1 H), 7.86-7.89 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 25.3, 51.5, 54.2, 123.1, 128.0 (C2), 129.4 (C2), 133.9, 138.6, 143.3, 166.0.
IR (KBr): 1728, 1659, 1447, 1323, 1204, 766, 748 cm-1. HRMS: m/z calcd for C12H14O4S [M+]: 254.0613; found: 254.0613.
Compound 20a (entry 2): MW (C14H18O4S): 282.35. 1H NMR (400 MHz, CDCl3): δ = 0.95 (t, J = 7.5 Hz, 3 H), 1.60-1.66 (m, 1 H), 1.84-1.87 (m, 1 H), 2.48-2.52 (m, 1 H), 2.68-2.72
(m, 1 H), 2.97-3.00 (m, 1 H), 3.67 (s, 3 H), 5.80 (dt, J = 15.6, 1.3 Hz, 1 H), 6.78 (dt, J = 15.6, 7.37 Hz, 1 H), 7.51-7.55 (m, 2 H), 7.60-7.64 (m, 1 H), 7.83-7.85 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 11.0, 20.7, 30.0, 51.5, 64.6, 123.8, 128.7 (C2), 129.2 (C2), 133.8, 137.6,
143.4, 166.0. IR (KBr): 1729, 1658, 1447, 1320, 1214, 731, 691 cm-1. HRMS: m/z calcd for C14H18O4S [M+]: 282.0926; found: 282.0929.
Compound 20a (entry 3): MW (C10H16O4): 186.21. 1H NMR (400 MHz, CDCl3): δ = 1.21 (t, J = 7.1 Hz, 3 H), 2.39-2.43 (m, 2 H), 2.46-2.51 (m, 2 H), 3.67 (s, 3 H), 4.10 (q, J = 7.1 Hz, 2 H), 5.82 (dt, J = 15.7, 1.5 Hz, 1 H), 6.91 (dt, J = 15.7, 6.3 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 14.1, 27.2, 32.4, 51.4, 60.5, 121.7, 146.9, 166.7, 172.1. IR (KBr): 1742, 1720,
1659, 1436, 1179, 1039, 859 cm-1. HRMS: m/z calcd for C9H14O4 [M+]: 186.0892; found: 186.0893.
Compound 20a (entry 4): MW (C7H9NO2): 139.15. 1H NMR (400 MHz, CDCl3): δ = 2.47-2.55 (m, 4 H), 3.72 (s, 3 H), 5.93 (dt, J = 15.7, 1.54 Hz, 1 H), 6.89 (dt, J = 15.7, 6.5 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 16.1, 27.7, 51.6, 118.2, 123.6, 143.3, 166.1. IR (KBr): 1730, 1663, 1437, 1275,
1213, 1162, 766, 748 cm-1. HRMS: m/z calcd for C7H9NO2 [M+]: 139.0633; found: 139.0642.
Compound 20a (entry 5): MW (C10H16O4: 200.23. 1H NMR (400 MHz, CDCl3): δ = 1.15 (d, J = 14.3 Hz, 3 H), 1.20 (t, J = 7.1 Hz, 3 H), 2.25-2.30 (m, 1 H), 2.50-2.57 (m, 2 H), 3.68 (s, 3 H), 4.09 (q, J = 7.1 Hz, 2 H), 5.82 (dt, J = 15.6, 1.1 Hz, 1 H), 6.84 (dt, J = 15.6, 6.9 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 14.1, 25.5, 35.8, 38.4, 51.4, 60.4, 122.8, 145.8, 166.6, 175.2. IR (KBr): 1740,
1720, 1659, 1436, 1275, 1196, 1180 cm-1. HRMS: m/z calcd for C10H16O4 [M+]: 200.1049; found: 200.1041.
Compound 20a (entry 6): MW (C14H16O3): 232.27. 1H NMR (400 MHz, CDCl3): δ = 1.21 (d, J = 7.0 Hz, 3 H), 2.30-2.36 (m, 1 H), 2.66-2.72 (m, 1 H), 3.54-3.59 (m, 1 H), 3.67
(s, 3 H), 5.84 (dt, J = 15.6, 1.5 Hz, 1 H), 6.91 (dt, J = 15.6, 6.9 Hz, 1 H), 7.43-7.46 (m, 2 H), 7.52-7.54 (m, 1 H), 7.90-7.92 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 17.5, 35.4, 39.8, 51.4, 122.8 (C2), 128.7 (C2), 133.1, 135.8, 146.3, 166.6,
202.4. IR (KBr): 1733, 1712, 1688, 1449, 1434, 971, 705 cm-1. HRMS: m/z calcd for C14H16O3 [M+]: 232.1099; found: 232.1086.
Compound 20a (entry 7): MW (C12H18O6): 258.26. 1H NMR (400 MHz, CDCl3): δ = 1.23 (t, J = 7.1 Hz, 6 H), 2.73-2.77 (m, 2 H), 3.44 (t, J = 7.44 Hz, 1 H), 3.68 (s, 3 H), 4.18 (q, J = 7.1 Hz, 4 H), 5.87 (dt, J = 15.6, 1.5 Hz, 1 H), 6.86 (dt, J = 15.6, 7.1 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 14.0 (C2), 31.0, 50.6, 51.5, 61.7 (C2), 123.8, 144.0, 166.3, 168.2 (C2). IR
(KBr): 1755, 1720, 1661, 1436, 1151, 1036, 774 cm-1. HRMS: m/z calcd for C12H18O6 [M+]: 258.1103; found: 258.1128.
Compound 20b (entry 1): MW (C13H16O4S): 268.32. 1H NMR (400 MHz, CDCl3): δ = 1.19 (d, J = 8.9 Hz, 3 H), 2.90-2.96 (m, 1 H), 3.06 (dd, J = 14.1, 6.3 Hz, 1 H), 3.17 (dd, J = 14.1, 6.6 Hz, 1 H), 3.65 (s, 3 H), 5.72 (dd, J = 15.6, 1.0 Hz, 1 H), 6.71 (dd, J = 15.6, 7.6 Hz, 1 H), 7.50-7.55 (m, 2 H), 7.59-7.63 (m, 1 H), 7.84-7.90 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 19.5, 31.6, 51.5, 60.9, 120.9, 127.8 (C2), 129.2 (C2), 133.7, 139.4, 149.5,
166.3. IR (KBr): 1721, 1659, 1447, 1305, 1209, 766, 747 cm-1. HRMS: m/z calcd for C13H16O4S [M+]: 268.0769; found: 2268.0751.
Compound 20b (entry 2): MW (C15H20O4S): 296.38. Ratio syn/anti = 1.67:1 (from 1H NMR). 1H NMR (400 MHz, CDCl3): δ(anti) = 0.90 (t, J = 7.5 Hz, 3 H), 1.19 (d, J = 7.0 Hz, 3 H), 1.67-1.70 (m, 1 H), 1.84-1.88 (m, 1 H), 2.88-2.91 (m, 1 H), 3.05-3.12
(m, 1 H), 3.69 (s, 3 H), 5.77 (dd, J = 15.7, 1.4 Hz, 1 H), 6.99 (dd, J = 15.7, 7.0 Hz, 1 H), 7.51-7.55 (m, 2 H), 7.60-7.63 (m, 1 H), 7.84-7.87 (m, 2 H);
δ(syn) = 0.85 (t, J = 7.5 Hz, 3 H), 1.21 (d, J = 7.0 Hz, 3 H), 1.67-1.70 (m, 1 H), 1.84-1.88 (m, 1 H), 2.95-2.99 (m, 1 H), 3.05-3.12
(m, 1 H), 3.68 (s, 3 H), 5.76 (dd, J = 15.7, 1.7 Hz, 1 H), 6.83 (dd, J = 15.7, 6.3 Hz, 1 H), 7.51-7.55 (m, 2 H), 7.60-7.63 (m, 1 H), 7.84-7.87 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 12.9, 13.0, 13.1, 13.4, 17.8, 18.9, 34.5, 34.8, 51.5, 51.6, 69.1, 70.5, 121.1,
121.9, 128.4 (C2), 128.6 (C2), 129.2 (C2), 129.3 (C2), 133.6, 133.7, 138.7, 138.9,
148.3, 150.5, 166.4, 166.5. IR (KBr): 1727, 1656, 1447, 1303, 1197, 765, 728 cm-1. HRMS: m/z calcd for C15H20O4S [M+]: 296.1082; found: 296.1089.
Compound 20b (entry 3): MW (C10H16O4): 200.23. 1H NMR (400 MHz, CDCl3): δ = 1.07 (d, J = 6.7 Hz, 3 H), 1.20 (t, J = 7.1 Hz, 3 H), 2.27 (dd, J = 15.3 Hz, 7.2 Hz, 1 H), 2.36 (dd, J = 15.3, 7.1 Hz, 1 H), 2.77-2.84 (m, 1 H), 3.67 (s, 3 H), 4.08 (q, J = 7.1 Hz, 2 H), 5.79 (dd, J = 15.7, 1.2 Hz, 1 H), 6.86 (dd, J = 15.7, 7.3 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 14.1, 18.9, 32.9, 40.3, 51.4, 60.4, 119.8, 152.0, 166.9, 171.5. IR (KBr): 1738,
1722, 1658, 1276, 1177, 765, 748 cm-1. HRMS: m/z calcd for C10H16O4 [M+]: 200.1049; found: 200.1048.
Compound 20b (entry 4): MW (C8H11NO2): 153.17. 1H NMR (400 MHz, CDCl3): δ = 1.21 (d, J = 6.8 Hz, 3 H), 2.35-2.46 (m, 2 H), 2.68-2.75 (m, 1 H), 3.70 (s, 3 H), 5.87 (dd,
J = 15.7, 1.2 Hz, 1 H), 6.82 (dd, J = 15.7, 7.2 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 18.6, 23.6, 33.1, 51.6, 117.5, 121.6, 148.7, 166.3. IR (KBr): 1728, 1659, 1436,
1277, 1197, 765, 749 cm-1. HRMS: m/z calcd for C8H11NO2 [M+]: 153.0790; found: 153.0781.
Compound 20b (entry 5): MW (C11H18O4): 214.25. Ratio syn/anti = 1:1 (from 1H NMR). 1H NMR (400 MHz, CDCl3): δ(syn) = 1.02 (d, J = 3.4 Hz, 3 H), 1.07 (t, J = 7.4 Hz, 3 H), 1.19 (t, J = 7.1 Hz, 3 H), 2.31-2.38 (m, 1 H), 2.55-2.65 (m, 1 H), 3.68 (s, 3 H), 4.06-4.14
(m, 2 H), 5.78 (dd, J = 15.7, 11.7 Hz, 1 H), 6.87 (dd, J = 15.7, 7.7 Hz, 1 H); δ(anti) = 1.03 (d, J = 3.2 Hz, 3 H), 1.07 (t, J = 7.4 Hz, 3 H), 1.22 (t, J = 7.1 Hz, 3 H), 2.41-2.48 (m, 1 H), 2.55-2.65 (m, 1 H), 3.69 (s, 3 H), 4.06-4.14
(m, 2 H), 5.79 (dd, J = 15.6, 10.8 Hz, 1 H), 6.77 (dd, J = 15.6, 8.6 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 13.4, 14.1, 14.2, 14.8, 15.5, 17.6, 38.9, 39.5, 43.9, 44.5, 51.4, 51.5, 60.3,
60.4, 120.6, 121.3, 150.9, 151.4, 166.8, 166.9, 174.8, 175.0. IR (KBr): 1735, 1723,
1658, 1435, 1277, 1243, 765, 748 cm-1. HRMS: m/z calcd for C11H18O4 [M+]: 214.1205; found: 214.1203.
Compound 20b (entry 6): MW (C15H18O3): 246.30. Ratio syn/anti = 1.67:1 (from 1H NMR). 1H NMR (400 MHz, CDCl3): δ(anti) = 1.03 (d, J = 6.8 Hz, 3 H), 1.15 (d, J = 6.9 Hz, 3 H), 2.76-2.84 (m, 1 H), 3.47-3.54 (m, 1 H), 3.66 (s, 3 H), 5.77-5.85
(m, 1 H), 6.94 (dd, J = 15.7, 7.4 Hz, 1 H), 7.42-7.47 (m, 2 H), 7.51-7.55 (m, 1 H), 7.87-7.93 (m, 2 H);
δ(syn) = 1.02 (d, J = 6.6 Hz, 3 H), 1.11 (d, J = 6.9 Hz, 3 H), 2.76-2.84 (m, 1 H), 3.38-3.41 (m, 1 H), 5.77-5.85 (m, 1 H), 6.87
(dd, J = 15.6, 8.9 Hz, 1 H), 7.42-7.47 (m, 2 H), 7.51-7.55 (m, 1 H), 7.87-7.93 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 13.4, 14.9, 16.0, 18.4, 38.2, 39.4, 44.6, 45.2, 51.4, 51.5, 120.5 (C2), 121.3,
128.1 (C2), 128.7 (C2), 133.0, 133.1, 136.4, 136.8, 151.3, 151.9 (C2), 166.8, 166.9,
202.6, 203.2. IR (KBr): 1722, 1681, 1655, 1449, 1277, 765, 748 cm-1. HRMS: m/z calcd for C15H18O3 [M+]: 246.1256; found: 246.1255.
Compound 20b (entry 7): MW (C13H20O6): 272.29. 1H NMR (400 MHz, CDCl3): δ = 1.12 (d, J = 6.8 Hz, 3 H), 1.20 (t, J = 7.1 Hz, 3 H), 1.23 (t, J = 7.1 Hz, 3 H), 3.04-3.10 (m, 1 H), 3.30 (d, J = 8.5 Hz, 1 H), 3.68 (s, 3 H), 4.13 (t, J = 7.1 Hz, 2 H), 4.17 (t, J = 7.1 Hz, 2 H), 5.83 (dd, J = 15.6, 0.7 Hz, 1 H), 6.87 (dd, J = 15.6, 8.1 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 13.9, 14.0, 17.3, 36.2, 51.4, 56.7, 61.4, 61.5, 121.4, 149.3, 166.6, 167.6,
167.7. IR (KBr): 1756, 1722, 1658, 1436, 1300, 1278, 1234, 988 cm-1. HRMS: m/z calcd for C13H20O6 [M+]: 272.1260; found: 272.1271.
Compound 23: MW (C15H18O4S): 294.37. 1H NMR (400 MHz, CDCl3): δ = 1.36-1.44 (m, 1 H), 1.50-1.56 (m, 1 H), 1.68-1.74 (m, 1 H), 1.87-1.93 (m, 1
H), 2.10-2.17 (m, 1 H), 2.21-2.27 (m, 1 H), 2.85-2.89 (m, 1 H), 3.04 (dd, J = 14.1, 6.9 Hz, 1 H), 3.13 (dd, J = 14.1, 6.1 Hz, 1 H), 3.66 (s, 3 H), 6.74-6.75 (m, 1 H), 7.52-7.56 (m, 2 H), 7.60-7.64
(m, 1 H), 7.88-7.90 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 20.3, 23.8, 27.8, 31.1, 51.6, 60.4, 127.8, 129.3, 132.1, 133.7, 139.0, 139.7,
167.3. IR (KBr): 1715, 1447, 1276, 1255, 1151, 1086, 719 cm-1. HRMS: m/z calcd for C15H18O4S [M+]: 294.0926; found: 294.0936.
Compound 28: MW (C18H26O6): 338.39. 1H NMR (400 MHz, CDCl3): δ = 0.84-0.95 (m, 1 H), 1.17-1.25 (m, 8 H), 1.49-1.59 (m, 1 H), 1.74-1.80 (m, 2
H), 2.62-2.73 (m, 2 H), 2.79-2.84 (m, 1 H), 3.28-3.36 (m, 2 H), 3.65 (s, 3 H), 4.07-4.22
(m, 4 H), 4.55-4.57 (m, 1 H), 4.90-4.91 (m, 1 H). 13C NMR (100 MHz, CDCl3): δ = 13.9, 14.0, 21.5, 23.2, 24.6, 37.8, 41.9, 44.4, 45.4, 51.5, 60.9, 61.4, 61.5,
107.4, 145.4, 169.5, 171.7, 174.9. IR (KBr): 1731, 1446, 1268, 1254, 1224, 1058, 1038,
1015 cm-1. HRMS: m/z calcd for C18H26O6 [M+]: 338.1729; found: 338.1750.